50 related articles for article (PubMed ID: 25819559)
1. p-Aminophenyl-α-D-mannopyranoside engineered lipidic nanoparticles for effective delivery of docetaxel to brain.
Singh I; Swami R; Jeengar MK; Khan W; Sistla R
Chem Phys Lipids; 2015 May; 188():1-9. PubMed ID: 25819559
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein E3 functionalized lipid-drug conjugated nanoparticles of Levetiracetam for enhanced delivery to the brain: In-vitro cell line studies and in-vivo study.
Athalye M; Teli D; Chorawala M; Sharma A; Patel R; Dua K; Singh SK; Gupta G; Patel M
Int J Biol Macromol; 2024 Jan; 254(Pt 2):127799. PubMed ID: 37923037
[TBL] [Abstract][Full Text] [Related]
3. Lipidic Formulations Inspired by COVID Vaccines as Smart Coatings to Enhance Nanoparticle-Based Cancer Therapy.
Conte M; Carofiglio M; Rosso G; Cauda V
Nanomaterials (Basel); 2023 Aug; 13(15):. PubMed ID: 37570567
[TBL] [Abstract][Full Text] [Related]
4. A Novel, Nontoxic and Scalable Process to Produce Lipidic Vehicles.
Naziris N; Pippa N; Demetzos C
Materials (Basel); 2020 Nov; 13(21):. PubMed ID: 33171678
[TBL] [Abstract][Full Text] [Related]
5. Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting.
Swami R; Singh I; Jeengar MK; Naidu VG; Khan W; Sistla R
Int J Pharm; 2015; 486(1-2):287-96. PubMed ID: 25839415
[TBL] [Abstract][Full Text] [Related]
6. Lactoferrin bioconjugated solid lipid nanoparticles: a new drug delivery system for potential brain targeting.
Singh I; Swami R; Pooja D; Jeengar MK; Khan W; Sistla R
J Drug Target; 2016; 24(3):212-23. PubMed ID: 26219519
[TBL] [Abstract][Full Text] [Related]
7. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
[TBL] [Abstract][Full Text] [Related]
8. Targeted Glioma Therapy-Clinical Trials and Future Directions.
Shikalov A; Koman I; Kogan NM
Pharmaceutics; 2024 Jan; 16(1):. PubMed ID: 38258110
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biological Rhythms in New Drug Formulations to Cross the Brain Barriers.
Mineiro R; Albuquerque T; Neves AR; Santos CRA; Costa D; Quintela T
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37628722
[TBL] [Abstract][Full Text] [Related]
10. Chitosomes Loaded with Docetaxel as a Promising Drug Delivery System to Laryngeal Cancer Cells: An In Vitro Cytotoxic Study.
Moya-Garcia CR; Li-Jessen NYK; Tabrizian M
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373051
[TBL] [Abstract][Full Text] [Related]
11. Multimodal targeting of glioma with functionalized nanoparticles.
Marei HE
Cancer Cell Int; 2022 Aug; 22(1):265. PubMed ID: 35999629
[TBL] [Abstract][Full Text] [Related]
12. Adenosine Conjugated Docetaxel Nanoparticles-Proof of Concept Studies for Non-Small Cell Lung Cancer.
Aldawsari HM; Singh S; Alhakamy NA; Bakhaidar RB; Halwani AA; Sreeharsha N; Badr-Eldin SM
Pharmaceuticals (Basel); 2022 Apr; 15(5):. PubMed ID: 35631370
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?
Pinheiro RGR; Coutinho AJ; Pinheiro M; Neves AR
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769082
[TBL] [Abstract][Full Text] [Related]
14. Lipid nanostructures for targeting brain cancer.
Nsairat H; Khater D; Odeh F; Al-Adaileh F; Al-Taher S; Jaber AM; Alshaer W; Al Bawab A; Mubarak MS
Heliyon; 2021 Sep; 7(9):e07994. PubMed ID: 34632135
[TBL] [Abstract][Full Text] [Related]
15. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms.
Song J; Lu C; Leszek J; Zhang J
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576281
[TBL] [Abstract][Full Text] [Related]
16. Evolution of blood-brain barrier in brain diseases and related systemic nanoscale brain-targeting drug delivery strategies.
Han L; Jiang C
Acta Pharm Sin B; 2021 Aug; 11(8):2306-2325. PubMed ID: 34522589
[TBL] [Abstract][Full Text] [Related]
17. cRGDyK-modified procaine liposome inhibits the proliferation and motility of glioma cells via the ERK/p38MAPK pathway.
Li D; Gao J; Yang C; Li B; Sun J; Yu M; Wang Y; Wang H; Lu Y
Exp Ther Med; 2021 Aug; 22(2):859. PubMed ID: 34178132
[TBL] [Abstract][Full Text] [Related]
18. Lipid-Based Nanocarriers for The Treatment of Glioblastoma.
Iturrioz-Rodríguez N; Bertorelli R; Ciofani G
Adv Nanobiomed Res; 2021 Feb; 1(2):2000054. PubMed ID: 33623931
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery.
Torres-Pérez SA; Torres-Pérez CE; Pedraza-Escalona M; Pérez-Tapia SM; Ramón-Gallegos E
Front Oncol; 2020; 10():605037. PubMed ID: 33330106
[TBL] [Abstract][Full Text] [Related]
20. Brain targeted delivery of anticancer drugs: prospective approach using solid lipid nanoparticles.
Anand A; Sugumaran A; Narayanasamy D
IET Nanobiotechnol; 2019 Jun; 13(4):353-362. PubMed ID: 31171738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
